Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank14
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-180.89M
↓ 156% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-70.67M
Historical baseline
PeriodValueYoY Change
2025$-180.89M+6.3%
2024$-192.95M-17.5%
2023$-164.16M-25.7%
2022$-130.65M-194.4%
2021$138.38M+1354.6%
2020$-11.03M+24.5%
2019$-14.61M-54.1%
2018$-9.48M-